Cibus appoints August Moretti to Board of Directors and Audit Committee effective Nov 18, 2024

Cibus, Inc.

August Moretti, 74, appointed as director and Audit Committee member effective November 18, 2024.
Moretti most recently served as CFO of 4D Molecular Therapeutics until Sept 2023; prior CFO roles at Assertio and Alexza Pharmaceuticals.
He will receive compensation per Cibus Non-Employee Director Compensation Policy and standard indemnification agreement.
No arrangements with other persons exist; no material interest in transactions requiring disclosure.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

August Moretti

Director

CBUS · Cibus, Inc.

Effective: 2024-11-18
Filed: November 18, 2024, 6:59 PM ET

On November 18, 2024, the Board of Directors (the “Board”) of Cibus, Inc. (the “Company”) appointed August Moretti to serve as a member of the Board, effective as of such date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

August Moretti was appointed as Director at Cibus, Inc..

Action: appointed
Role: Director

Exact text from the filing

On November 18, 2024, the Board of Directors (the “Board”) of Cibus, Inc. (the “Company”) appointed August Moretti to serve as a member of the Board, effective as of such date.

View on SEC.gov

Cibus, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-048288

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.